Dr Morepen Eyes Rs 500-Crore Revenue From Wellness Business In Four Years

NEWS COVERAGE

लाइटलाइफ़ के साथ डॉ. मोरपेन ने रखा वेलनेस सेगमेंट में कदम

NEWS COVERAGE

Dr Morepan ने लॉन्च किए वैलनेस प्रोडक्ट, 12,000 करोड़ के वेट मैनेजमेंट बाजार में दस्तक

NEWS COVERAGE

भारत में मोटापा बढ़ा रहा खतरा, डॉ. मोरपेन का 'लाइटलाइफ' बन सकता है गेमचेंजर! जानिए कैसे करेगा काम

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Dr. Morepen enters wellness segment with weight management solution, focuses on India market

NEWS COVERAGE

PRESS RELEASE

Dr Morepan ने वैलनेस प्रोडक्ट लॉन्च किए, इनके जरिए घटा सकते हैं अपना वजन

NEWS COVERAGE

Dr Morepen Launches Weight Management Initiative

NEWS COVERAGE

Dr Morepen Tackles Obesity with New Wellness Initiative

NEWS COVERAGE

LIGHTLIFE LAUNCH MARKS DR MOREPEN’S FORAY INTO WELLNESS SEGMENT

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Maximum Doctors Pledge to Help Indians Enjoy the Freedom of Good Gut Health

NEWS COVERAGE

PRESS RELEASE

Morepen Lab Standalone September 2024 Net Sales at Rs 383.70 crore, up 0.64% Y-o-Y

NEWS COVERAGE

Morepen Labs Q2 Net Profit Jumps Over 6-fold To Rs 27 Cr

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 63.92% in the September 2024 quarter

NEWS COVERAGE

PRESS RELEASE

The speed of innovation is both a challenge and an opportunity

NEWS COVERAGE

NEWS COVERAGE

Dr. Morepen’s diabetes awareness campaign kicks on KBC

NEWS COVERAGE

PRESS RELEASE

Morepen Laboratories Reaches New Heights Market Cap Surpasses Rs. 5000 Crore

NEWS COVERAGE

Morepen Laboratories: Smallcap Pharma Company Shines with Record High Stock Performance

NEWS COVERAGE

Morepen Laboratories' Stock Reaches 52-Week High, Outperforms Sector and Sensex

NEWS COVERAGE

Morepen Laboratories Reaches New Heights: Market Cap Surpasses Rs. 5000 Crore

NEWS COVERAGE

Morepen Labs shares hit fresh one-year high as stock rallies 56% in a month; here's why

NEWS COVERAGE

The stock hit a multi-year high of Rs 88.85 was trading 63 per cent higher against its qualified institutional placement (QIP) price of Rs 54.37 per share.

NEWS COVERAGE

Why Morepen Laboratories Share Price is Rising

NEWS COVERAGE

NEWS COVERAGE

Dr. Morepen: Your Partner in Health with Omega-3

INVESTOR UPDATE

Morepen Labs stock hits 52-week high logging 15% intraday rally. More steam left?

NEWS COVERAGE

Here's why Mayuresh Joshi is bullish on Morepen Labs

NEWS COVERAGE

Morepen Labs launches Rs 250 crore QIP with greenshoe option

NEWS COVERAGE

Morepen Labs Q1 FY25 Profit Surges by 147%, Revenue Grows by 14% Morepen Labs successfully raised Rs. 200 Crore through QIP

NEWS COVERAGE

Breakout stocks to buy: Matrimony to Morepen Lab

NEWS COVERAGE

Financial results Q1-2024-25

NEWS COVERAGE

PRESS RELEASE

PRESS RELEASE

INVESTOR UPDATE

PRESS RELEASE

Here's why Mayuresh Joshi is bullish on Morepen Labs

NEWS COVERAGE

Morepen Labs successfully raises Rs.200 crore through QIP

NEWS COVERAGE

PRESS RELEASE

Morepen Labs launches Rs 250 crore QIP with greenshoe option

NEWS COVERAGE

Morepen Laboratories Launches Rs 250-Crore QIP

NEWS COVERAGE

Morepen Laboratories launches QIP to raise up to ₹200 crore

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 243.20% in the March 2024 quarter

NEWS COVERAGE

Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

NEWS COVERAGE

Dr. Morepen’s Revolutionary Intelicaps® Technology for Enhanced Probiotic Delivery, First time in India

NEWS COVERAGE

Gut Reaching Probiotics – Revolutionary, Intebact

NEWS COVERAGE

Pharma stock under ₹ 50 jumps 9% after company announces net profit increase of 249% in Q4

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 243.20% in the March 2024 quarter

NEWS COVERAGE

Morepen Lab Standalone March 2024 Net Sales at Rs 392.60 crore, up 16.66% Y-o-Y

NEWS COVERAGE

PRESS RELEASE

Burnol . Lifespring and now lemolate ; Dr. Morepen Brand Basket grows

NEWS COVERAGE

Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India

PRESS RELEASE

PRESS RELEASE

Morepen Laboratories Limited’ Q3 FY24 EBITDA Surges By 151 Per Cent, Net Profit Records A Remarkable 256 Per Growth

PRESS RELEASE

PRESS RELEASE

Morepen - The Future of Home Diagnostics and OTC Health Products

PRESS RELEASE

PRESS RELEASE

Mr. Sushil Suri, Chairman & MD of Morepen Laboratories Ltd. honored to be the chief guest of the Annual Graduation & Convocation Ceremony of Chandigarh University.

PRESS RELEASE

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr Morepen launches advanced Muscle Food to fuel performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr Morepen launches advanced muscle food

PRESS RELEASE

Dr. Morepen launches advanced Pre-workout Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Morepen Labs introduces advanced muscle food

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

Dr. Morepen launches advanced muscle food

PRESS RELEASE

Dr. Morepen launches advanced Muscle Food to fuel your performance

PRESS RELEASE

PRESS RELEASE

Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine (Allegra)

PRESS RELEASE

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen Laboratories receives USFDA approval for Fexofinadin

PRESS RELEASE

Morepen gets USFDA nod to market generic anti-allergy drug

PRESS RELEASE

Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen gets USFDA nod for anti-allergy drug

PRESS RELEASE

Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine

PRESS RELEASE

Noticias farmacéuticas: Últimas noticias farmacéuticas, noticias y actualizaciones farmacéuticas indias

PRESS RELEASE

Actualités pharmaceutiques : dernières actualités pharmaceutiques, actualités pharmaceutiques indiennes et mises à jour

PRESS RELEASE

Morepen Labs’ exports to get ‘major boost’ with FDA nod for Allegra

PRESS RELEASE

Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen gets USFDA nod for Fexofinadine (Allegra)

PRESS RELEASE

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

PRESS RELEASE

Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22

PRESS RELEASE

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

PRESS RELEASE

This news turns out to be a lucky charm for Morepen Laboratories; read to find out more!

PRESS RELEASE

Morepen gets USFDA nod to market generic anti-allergy drug

PRESS RELEASE

Morepen bags US FDA approval for allergy drug Allegra

PRESS RELEASE

Morepen gets USFDA nod to market generic anti-allergy drug

PRESS RELEASE

Morepen gets USFDA nod to market generic anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen Laboratories receives USFDA approval

PRESS RELEASE

Morepen Labs has seen 36% growth in medical devices in Q2, Dr Morepen could be an IPO candidate: Sushil Suri

PRESS RELEASE

Morepen Laboratories gets USFDA nod for Fexofinadine

PRESS RELEASE

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

PRESS RELEASE

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

PRESS RELEASE

Morepen Laboratories gets USFDA nod to market generic anti-allergy drug

PRESS RELEASE

Morepen gets USFDA nod to market generic anti-allergy drug

PRESS RELEASE

Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22

PRESS RELEASE

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Laboratories Ltd consolidated Q2FY22 PAT at Rs. 37.36 crore

PRESS RELEASE

Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore

PRESS RELEASE

Morepen records 70 percent increase in Profit before tax in Q2 Consolidated Revenue grows by 17%

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit rises 38% at Rs. 37.36 crore

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 crore

PRESS RELEASE

Morepen Laboratories Sept-Quarter Consol Net Profit Rises

PRESS RELEASE

Morepen Laboratories Sept-Quarter Consol Net Profit Rises

PRESS RELEASE

: Morepen Labs Q2 Results: Net Profit Up 38%

PRESS RELEASE

Morepen Labs Q2 Results: Net Profit Up 38%

PRESS RELEASE

Morepen Laboratories Q2

PRESS RELEASE

Morepen Laboratories reports rise in Q2 net profit

PRESS RELEASE

Morepen Laboratories consolidated net profit rises 37.50% in the September 2021 quarter

PRESS RELEASE

Morepen records 70 percent increase in Profit before tax in Q2 with consolidated revenue growth of 17%

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

Morepen records 70% increase in profit before tax in Q2

PRESS RELEASE

Morepen Labs Q2 net profit up 38 %

PRESS RELEASE

Morepen Labs Q2 net profit up 38 pc to Rs 37 cr

PRESS RELEASE

PRESS RELEASE

INVESTOR UPDATE

Boman Irani stars in Dr Morepen's latest ad

PRESS RELEASE

Morepen ropes in Boman Irani for their Medical Devices Campaign

PRESS RELEASE

Morepen Ropes In Boman Irani For Their Medical Devices Campaign

PRESS RELEASE

Morepen shareholders approve new unit to house medical device biz

PRESS RELEASE

Morepen shareholders approve new unit to house medical device biz

PRESS RELEASE

Morepen shareholders approve new unit to house medical device business

PRESS RELEASE

Morepen shareholders approve new unit to house medical device business

PRESS RELEASE

Morepen Lab carves out its Medical Devices into a Subsidiary  

PRESS RELEASE

Morepen Lab carves out its Medical Devices into a Subsidiary

PRESS RELEASE

Morepen Labs Forms New Subsidiary For Medical Devices

PRESS RELEASE

PRESS RELEASE

Morepen Lab soars 7.5% after board approves divestment of Medical Devices Business through slump sale

NEWS COVERAGE

Morepen Lab shares jump over 8 pc

NEWS COVERAGE

मोरपेन लेबोरेटरीज के शेयरों में 11 फीसदी की वृद्धि

NEWS COVERAGE

Morepen Labs board approves transfer of POC medical devices business into wholly-owned subsidiary

NEWS COVERAGE

Morepen shares surge 11% on hiving off medical device business

NEWS COVERAGE

Morepen shares surge 11% on hiving off medical device business

NEWS COVERAGE

Morepen Laboratories shares surge 11% on hiving off medical device business

NEWS COVERAGE

Morepen Labs board approves POC medical devices biz into wholly-owned subsidiary

NEWS COVERAGE

Morepen Labs Board approves medical devices business into a wholly-owned subsidiary

NEWS COVERAGE

Morepen shares surge 11% on hiving off medical device business

NEWS COVERAGE

Morepen shares surge 11% on hiving off medical device business

NEWS COVERAGE

Morepen Labs jumps 11% on transfer of medical devices biz to subsidiary

NEWS COVERAGE

1.     The Economic Times - [Morepen Labs jumps 11% on transfer of medical devices biz to subsidiary]

NEWS COVERAGE

Sushil Suri Of Morepen Lab Speaks On Q1 Performance And Growth Ahead | Halftime Report | CNBC-TV18

NEWS COVERAGE

Morepen Labs Q1 net profit rises 57% at Rs. 30.47 crore

NEWS COVERAGE

Morepen Laboratories Q1 profit jumps 57 pc to Rs 30.47 cr

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

मोरपेन लेबोरेटरीज का मुनाफा पहली तिमाही में 57 फीसदी बढ़ा

NEWS COVERAGE

Morepen Laboratories Q1 profit jumps 57% to Rs 30.47 cr

NEWS COVERAGE

Morepen Labs' net revenue up 50 per cent to Rs 388.31 Cr in Q1 FY’22

NEWS COVERAGE

Morepen records highest ever quarterly revenue Rs388.31cr in Q1FY22, growth of 50% yoy; Stock ends higher

NEWS COVERAGE

Morepen Labs Profit Rises 57% To ₹ 30 Crore In June Quarter, Stock Gains 3%

NEWS COVERAGE

Morepen Laboratories Q1FY22: Profit jumps 57% to Rs 30.47 cr

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

Morepen Lab gains after Q1 PAT rises 57% YoY

NEWS COVERAGE

Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 cr

NEWS COVERAGE

Morepen Lab Consolidated June 2021 Net Sales at Rs 386.73 crore, up 50.1% Y-o-Y

NEWS COVERAGE

Plan is to make key intermediates for production and reduce dependence on China, says Morepen Lab

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

Morepen Laboratories profit jumps 57%

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

PRESS RELEASE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Lab starts producing Sputnik V

NEWS COVERAGE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Labs in Himachal starts production of Sputnik V test batch

NEWS COVERAGE

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

NEWS COVERAGE

Morepen Labs starts Test Production of Sputnik V at Himachal facility

NEWS COVERAGE

India’s Morepen Labs starts production of Russia’s Sputnik V

NEWS COVERAGE

 RDIF and Morepen Laboratories to produce test batch of Sputnik V

NEWS COVERAGE

 Morepen Labs begins production of trial batch of Sputnik V vaccine in Himachal Pradesh

NEWS COVERAGE

 Morepen Labs begins trial production of Sputnik V

NEWS COVERAGE

 Drugmaker, Russian sovereign fund RDIF inked pact in June, tech transfer underway

NEWS COVERAGE

Morepen Laboratories produces 1st test batch of Sputnik V: RDIF

NEWS COVERAGE

 RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India

NEWS COVERAGE

 RDIF, Morepen Laboratories in partnership for Sputnik V vaccine

NEWS COVERAGE

 RDIF and Morepen Labs announce production of test batch of Sputnik V vaccine in India

NEWS COVERAGE

 Morepen Lab hits record high after announcement of production of the test batch of Sputnik V with RDIF in India

NEWS COVERAGE

 स्पूतनिक-वी का भारत में उत्पादन शुरू, मोरपेन लेबोरेटरीज ने तैयार किया पहला टेस्ट बैच

NEWS COVERAGE

 India's Morepen makes first test batch of Russia's Sputnik V shot - fund

NEWS COVERAGE

 Russian Direct Investment Fund & Morepen Laboratories Announced the Production ... - Latest Tweet by ANI

NEWS COVERAGE

 Morepen Labs starts production of test batch of Sputnik V vaccine

NEWS COVERAGE

 Morepen Labs starts production of test batch of Sputnik V vaccine

NEWS COVERAGE

India's Morepen makes first test batch of Russia's Sputnik V shot - fund

NEWS COVERAGE

 Morepen makes 1st test batch of Russia's Sputnik V vaccine

NEWS COVERAGE

 Morepen Labs in Himachal begins production of Sputnik V’s test batch

NEWS COVERAGE

 Morepen Labs starts production of test batch of Sputnik V vaccine

NEWS COVERAGE

Morepen Labs starts production of test batch of Russia’s Sputnik V COVID-19 vaccine

NEWS COVERAGE

 Morepen manufactures 1st test batch of Sputnik V vaccine: RDIF

NEWS COVERAGE

 Morepen Labs In Himachal Starts Production Of Test Batch Of Sputnik V Vaccine

NEWS COVERAGE

 India’s Morepan Labs manufactures test batch of Russia’s Sputnik V vaccine: RDIF

NEWS COVERAGE

 Morepen Labs begins trial production of Sputnik V

NEWS COVERAGE

Sputnik V Covid vaccine: India's Morepen Labs makes first test batch

NEWS COVERAGE

 Morepen Labs Begins Production Of Trial Batch Of Sputnik V Vaccine

NEWS COVERAGE

 RDIF, Morepen Lab to produce test batch of Sputnik V vaccine in Himachal Pradesh

NEWS COVERAGE

 Morepen Labs begins trial production of Sputnik V

NEWS COVERAGE

 COVID-19 vaccine update | India's Morepen Laboratories makes first test batch of Russia's Sputnik V shot: RDIF

NEWS COVERAGE

 Sputnik V Vaccine: Morepen Labs commences producing test batch at Himachal facility

NEWS COVERAGE

मोरपेन लेबोरेटरीज ने टेस्‍ट बैच के लिए शुरू किया प्रोडक्‍शन, रूस सेंटर में होगी जांच

NEWS COVERAGE

 Morepen Labs starts production of test batch of Sputnik V vaccine in Himachal Pradesh

NEWS COVERAGE

 Sputnik V Covid vaccine: India's Morepen Labs makes first test batch

NEWS COVERAGE

 Morepen Labs starts production of test batch of Sputnik V vaccine

NEWS COVERAGE

 India's Morepen makes first test batch of Russia's Sputnik V shot - fund

NEWS COVERAGE

 India's Morepen Labs manufactures test batch of Russia's Sputnik V vaccine: RDIF

NEWS COVERAGE

 Morepen Laboratories produces test batch of Sputnik V coronavirus vaccine

NEWS COVERAGE

 Morepen produces 1st test batch of Russia's Sputnik V Covid vaccine in Himachal Pradesh

NEWS COVERAGE

 RDIF, Morepen Laboratories make test batch of Sputnik V in India

NEWS COVERAGE

 Sputnik V Covid vaccine: India's Morepen Labs makes first test batch

NEWS COVERAGE

 India's Morepen Labs starts production of test batch of Sputnik V vaccine

NEWS COVERAGE

PRESS RELEASE

INVESTOR ANNOUNCEMENTS

PRESS RELEASE

125% jump in a month, 360% in a year; safety rush turns this laggard a multibagger

NEWS COVERAGE

Nifty, Sensex under pressure – Tuesday closing report

NEWS COVERAGE

Morepen Laboratories Ltd Q4FY21 consolidated PAT at Rs. 26.76 crore

NEWS COVERAGE

Morepen Laboratories Q4 PAT doubles to Rs27cr led by robust API biz; Plans to set-up an R&D Centre at Baddi (HP)

NEWS COVERAGE

Morepen Laboratories Q4 net rises over two-fold to Rs 27 cr

NEWS COVERAGE

Morepen Laboratories Q4 net rises over two-fold to Rs 27 cr

NEWS COVERAGE

Morepen Laboratories Q4 net rises over two-fold to Rs 27 cr

PRESS RELEASE

Morepen Lab Consolidated March 2021 Net Sales at Rs 286.60 crore, up 38.72% Y-o-Y

NEWS COVERAGE

Morepen Laboratories posts two-fold jump in Q4 profit

NEWS COVERAGE

Morepen Laboratories Q4 net profit rises over two-fold to Rs 27 cr

PRESS RELEASE

PRESS RELEASE

Morepen Quarterly Results Coverage on CNBC Awaaz

NEWS COVERAGE

CMD, Sushil Suri's Interview on CNBC Bazaar

NEWS COVERAGE

This smallcap pharma stock has zoomed 101% in a month

NEWS COVERAGE

PRESS RELEASE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

CNBC TV18 Interview about $100M Fund Raise by Morepen

NEWS COVERAGE

NEWS COVERAGE

CNBC Awaaz: COVID Warriors Interview with CMD Sushil Suri

NEWS COVERAGE

Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories

NEWS COVERAGE

Morepen Group seals USD 100 million investment from Corinth Group of Switzerland

NEWS COVERAGE

THE MOREPEN COUNCIL RECEIVED A $ 100 MILLION INVESTMENT BY THE SWISS-BASED CORINTH GROUP | INSTANT NEWS

NEWS COVERAGE

Morepen Laboratories to raise over Rs 433 cr via issuance of shares on preferential basis

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland – ET HealthWorld

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland, Health News, ET HealthWorld

NEWS COVERAGE

Morepen board okays $100 million investment by Switzerland-based Corinth Group

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Seals Rs 750 Crore Investment From Corinth Group of Switzerland

NEWS COVERAGE

Morepen board okays $100 million investment by Switzerland-based Corinth Group-Business Journal

NEWS COVERAGE

Morepen board okays $100 million investment by Switzerland-based Corinth Group

NEWS COVERAGE

Morepen seals 750 rupees investment from Swiss Corinth Group, Health News and ET Health World

NEWS COVERAGE

Morepen Group seals $100mn investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Laboratories to raise over Rs 433 Cr

NEWS COVERAGE

Morepen Labs Expands POCDx Business

NEWS COVERAGE

Morepen Laboratories To Raise Over Rs 433 Cr

NEWS COVERAGE

Morepen Laboratories to raise over Rs 433 crore via issuance of shares on preferential basis

NEWS COVERAGE

Morepen Laboratories to raise over Rs 433 cr via issuance of shares on preferential basis

NEWS COVERAGE

We have 5 ANDAs in pipeline, says Morepen Lab

NEWS COVERAGE

Morepen Labs to expand POC Dx business

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Laboratories to raise over Rs 433 cr via issuance of shares on preferential basis

NEWS COVERAGE

Morepen board approves raising over Rs 433 crore

NEWS COVERAGE

Morepen Labs to raise over Rs 433 cr via issuance of shares on preferential basis

NEWS COVERAGE

Morepen Labs to raise over Rs 433 cr via issuance of preferential shares

NEWS COVERAGE

Morepen Labs to raise over Rs 433 cr via issuance of shares on preferential basis

NEWS COVERAGE

Morepen Labs to raise over Rs 433 cr via issuance of preferential shares

NEWS COVERAGE

Morepen Group seals $100mn investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Group seals ₹750-cr investment from Switzerland-based Corinth Group

NEWS COVERAGE

Morepen Group gets $100 million investment from Corinth Group

NEWS COVERAGE

Board of Morepen Lab approves investment proposed by Corinth Group

NEWS COVERAGE

Morepen Group receives investment of Rs. 750 crores from Corinth Group of Switzerland

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group

NEWS COVERAGE

Morepen Seals Rs 750 Crore Investment From Corinth Group of Switzerland

NEWS COVERAGE

Swiss investment firm Corinth bets on Morepen, plans India fund

NEWS COVERAGE

Morepen Group seals $100mn investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Labs seals $100 mn investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Group seals Rs 750 Cr investment to expand diagnostic biz

NEWS COVERAGE

Morepen seals Rs 750 crore investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Group seals USD 100 mn investment from Corinth Group of Switzerland

NEWS COVERAGE

Morepen Laboratories seals Rs750cr investment from Corinth Group of Switzerland

NEWS COVERAGE

Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories

NEWS COVERAGE

Swiss firm Corinth to invest $100 mn in Burnol owner Morepen

NEWS COVERAGE

Livemint: Morepen board okays $100 million investment by Switzerland-based Corinth Group

NEWS COVERAGE

Morepen board clears $100 million investment from Switzerland-based Corinth Group

NEWS COVERAGE

INVESTOR ANNOUNCEMENTS

PRESS RELEASE

PRESS RELEASE

NEWS COVERAGE

NEWS COVERAGE

PRESS RELEASE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

PRESS RELEASE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

INVESTOR UPDATE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE